Literature DB >> 21061003

Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study.

Ameneh Mashayekh1, Dzung L Pham, David M Yousem, Mercedes Dizon, Peter B Barker, Doris D M Lin.   

Abstract

INTRODUCTION: Extract of Ginkgo biloba (EGb), a dietary supplement used for a number of conditions including dementia, has been suggested to increase cerebral bloodflow (CBF). The purpose of this study was to determine if changes in CBF could be detected by dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI)in elderly human subjects taking EGb.
METHODS: DSC-MRI was performed in nine healthy men(mean age 61±10 years) before and after 4 weeks of 60 mg EGb taken twice daily. One subject underwent six consecutive scans to evaluate intrasubject reproducibility. CBF values were computed before and after EGb, and analyzed at three different levels of spatial resolution, using voxel-based statistical parametric mapping (SPM), and regions of interest in different lobes, and all regions combined.
RESULTS: Normalized intrasubject CBF (nCBF) measurements had a standard deviation of 7% and 4% in gray and white matter (WM) regions, respectively. SPM using an uncorrected, voxel-level threshold of P≤0.001 showed a small CBF increase in the left parietal-occipital region.CBF in individual lobar regions did not show any significant change post-EGb, but all regions combined showed a significant increase of non-normalized CBF after EGb (15% in white and 13% in gray matter, respectively, P≤0.0001).
CONCLUSION: nCBF measured by DSC-MRI has good intrasubject reproducibility. In this small cohort of normal elderly individuals, a mild increase in CBF is found in the left parietal-occipital WM after EGb, as well as a small but statistically significant increase in global CBF.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21061003      PMCID: PMC3163160          DOI: 10.1007/s00234-010-0790-6

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

1.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Authors:  P L Le Bars; M M Katz; N Berman; T M Itil; A M Freedman; A F Schatzberg
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

2.  Principles of cerebral perfusion imaging by bolus tracking.

Authors:  Leif Østergaard
Journal:  J Magn Reson Imaging       Date:  2005-12       Impact factor: 4.813

3.  Volumetric neuroimage analysis extensions for the MIPAV software package.

Authors:  Pierre-Louis Bazin; Jennifer L Cuzzocreo; Michael A Yassa; William Gandler; Matthew J McAuliffe; Susan S Bassett; Dzung L Pham
Journal:  J Neurosci Methods       Date:  2007-05-29       Impact factor: 2.390

4.  Ginkgo biloba extract and preventing Alzheimer disease.

Authors:  Lon S Schneider
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

5.  Relationship between white matter changes and cognition in healthy elders.

Authors:  Miho Ota; Kiyotaka Nemoto; Noriko Sato; Fumio Yamashita; Takashi Asada
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

6.  Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis.

Authors:  Søren Christensen; Kim Mouridsen; Ona Wu; Niels Hjort; Henrik Karstoft; Götz Thomalla; Joachim Röther; Jens Fiehler; Thomas Kucinski; Leif Østergaard
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

7.  Mapping the brain pathways of declarative verbal memory: Evidence from white matter lesions in the living human brain.

Authors:  Jorge Sepulcre; Joseph C Masdeu; Jaume Sastre-Garriga; Joaquín Goñi; Nieves Vélez-de-Mendizábal; Beatriz Duque; Maria A Pastor; Bartolomé Bejarano; Pablo Villoslada
Journal:  Neuroimage       Date:  2008-07-21       Impact factor: 6.556

8.  Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: evaluation of reproducibility and age- and gender-dependence with fully automatic image postprocessing algorithm.

Authors:  Wanyong Shin; Sandra Horowitz; Ann Ragin; Yufen Chen; Matthew Walker; Timothy J Carroll
Journal:  Magn Reson Med       Date:  2007-12       Impact factor: 4.668

9.  White matter lesion subtypes and cognitive deficits in patients with memory impairment.

Authors:  Vidar Stenset; Dag Hofoss; Audun Elnaes Berstad; Anne Negaard; Leif Gjerstad; Tormod Fladby
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-23       Impact factor: 2.959

10.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

View more
  15 in total

1.  Boosting your brain, part 1: the couch potato.

Authors:  M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-14       Impact factor: 3.825

2.  Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.

Authors:  Feng Chen; Li Li; Fang Xu; Yan Sun; Feifei Du; Xutao Ma; Chenchun Zhong; Xiuxue Li; Fengqing Wang; Nating Zhang; Chuan Li
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

3.  Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection.

Authors:  Z A Shah; S E Nada; S Doré
Journal:  Neuroscience       Date:  2011-02-18       Impact factor: 3.590

Review 4.  Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

5.  EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.

Authors:  Wen-bin Wan; Lan Cao; Lu-mei Liu; Bill Kalionis; Chuan Chen; Xian-tao Tai; Ya-ming Li; Shi-jin Xia
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

6.  A systematic review of research investigating the physiological and psychological effects of combining Ginkgo biloba and Panax ginseng into a single treatment in humans: Implications for research design and analysis.

Authors:  Jonathon Lee Reay; Paul van Schaik; Christopher James Wilson
Journal:  Brain Behav       Date:  2019-02-06       Impact factor: 2.708

Review 7.  Phytochemicals for Improving Aspects of Cognitive Function and Psychological State Potentially Relevant to Sports Performance.

Authors:  David O Kennedy
Journal:  Sports Med       Date:  2019-02       Impact factor: 11.136

8.  Ginkgo biloba extract protects human neuroblastoma SH-SY5Y cells against oxidative glutamate toxicity by activating redoxosome-p66Shc.

Authors:  Ke Wang; Jing Ni; Xue Zhu; Ling Zhu; Yue Li; Fanfan Zhou
Journal:  Exp Ther Med       Date:  2021-07-05       Impact factor: 2.447

9.  The Acute and Chronic Cognitive and Cerebral Blood Flow Effects of a Sideritis scardica (Greek Mountain Tea) Extract: A Double Blind, Randomized, Placebo Controlled, Parallel Groups Study in Healthy Humans.

Authors:  Emma L Wightman; Philippa A Jackson; Julie Khan; Joanne Forster; Felix Heiner; Bjoern Feistel; Cynthia G Suarez; Ivo Pischel; David O Kennedy
Journal:  Nutrients       Date:  2018-07-24       Impact factor: 5.717

Review 10.  Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma.

Authors:  Margarita Labkovich; Erica B Jacobs; Siddharth Bhargava; Louis R Pasquale; Robert Ritch
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.